← Back to Search

Procedure

Cyclophotocoagulation protocol for Glaucoma

N/A
Waitlist Available
Led By Andrew Toren, Doctor
Research Sponsored by CHU de Quebec-Universite Laval
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1h, 1 month, 6 months, 12 months, 18 months and 24 months post-op
Awards & highlights

Study Summary

This trial will help determine the best settings for transscleral cyclophotocoagulation to reduce intraocular pressure in case of glaucoma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1h, 1 month, 6 months, 12 months, 18 months and 24 months post-op
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1h, 1 month, 6 months, 12 months, 18 months and 24 months post-op for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intraocular pressure (IOP) evolution
Secondary outcome measures
Presence of complications
Retreatment
Use of medication
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Diode laser using modified settingsExperimental Treatment2 Interventions
The cyclophotocoagulation protocol is used with the modified cyclophotocoagulation settings of 1250 mW for 4 seconds.
Group II: Diode laser using conventional settingsActive Control2 Interventions
The cyclophotocoagulation protocol is used with the conventional cyclophotocoagulation settings of 2000 mW for 2 seconds.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cyclophotocoagulation protocol
2016
N/A
~50
Modified cyclophotocoagulation
2016
N/A
~50

Find a Location

Who is running the clinical trial?

CHU de Quebec-Universite LavalLead Sponsor
167 Previous Clinical Trials
107,113 Total Patients Enrolled
3 Trials studying Glaucoma
187 Patients Enrolled for Glaucoma
Andrew Toren, DoctorPrincipal InvestigatorCentre de recherche du CHU de Québec : Université Laval

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research currently accepting participants?

"Clinicaltrials.gov reveals that this research project is currently seeking participants, which was first reported on August 1st 2016 and its details were recently updated in March 2022."

Answered by AI

How many participants are contributing to this investigation?

"Affirmative. Clinicaltrials.gov indicates that this experiment, first launched on August 1st 2016, is currently accepting applicants. This research requires 50 participants from a solitary study location to be enrolled in the trial."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Cyclophotocoagulation in Glaucoma
2016. "Cyclophotocoagulation in Glaucoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02875158.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top